AQST · Aquestive Therapeutics Inc
United States · RS rating 44 · As of 2026-11-03
| Price | 3.88 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 27 / 74 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 20 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -85.7% |
| Sales growth Q/Q | +1.6% |
| Distance from 52-week high | +41.4% |
| Market cap (USD) | $496.7M |